Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12943-018-0931-9.

Title:
RETRACTED ARTICLE: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer | Molecular Cancer
Description:
Background Trastuzumab resistance followed by metastasis is a major obstacle for improving the clinical outcome of patients with advanced human epidermal growth factor receptor 2-positive (HER-2+) breast cancer. While long non-coding RNAs (lncRNAs) can modulate cell behavior, the contribution of these RNAs in trastuzumab resistance and metastasis of HER-2+ breast cancer is not well known. In this study, we sought to identify the regulatory role of lncRNA in trastuzumab resistance and accompanied Epithelial-mesenchymal Transition (EMT) process in advanced HER-2+ breast cancer. Methods Trastuzumab-resistant SKBR-3-TR and BT474-TR cell lines were established by grafting SKBR-3 and BT474 cells into mouse models and subjected to trastuzumab treatment. LncRNA microarray followed by quantitative reverse transcription PCR (qRT-PCR) was carried out to verify the differentially expressed lncRNAs. Western blotting, bioinformatics analysis, immunofluorescence assay and immunoprecipitation assays (ChIP and RIP) were performed to identify the involvement and functional interactions between H3K27 acetylation and terminal differentiation-induced non-coding RNA (TINCR) or between TINCR and its downstream genes including miR-125b, HER-2 and Snail-1. In addition, a series of in vitro and in vivo assays were performed to assess the functions of TINCR. Results An increase in both, IC50 value of trastuzumab and EMT was observed in the established trastuzumab-resistant cell lines. The expression level of TINCR was significantly increased in trastuzumab-resistant cells when compared with sensitive cells. Knockdown of TINCR reversed the trastuzumab resistance and the acquired EMT in these cells. TINCR was detected in the cytoplasm of breast cancer cells and could sponge miR-125b, thereby releasing HER-2 and inducing trastuzumab resistance. In addition, Snail-1 was found to be the target gene of miR-125b and overexpression of Snail-1 could reverse the suppressed migration, invasion, and EMT caused by TINCR silencing. The upregulation of TINCR in breast cancer was attributed to the CREB-binding protein (CBP)-mediated H3K27 acetylation at the promoter region of TINCR. Clinically, HER-2+ breast cancer patients with high TINCR expression levels were associated with poor response to trastuzumab therapy and shorter survival time. Conclusion TINCR could promote trastuzumab resistance and the accompanied EMT process in breast cancer. Therefore, TINCR might be a potential indicator for prognosis and a therapeutic target to enhance the clinical efficacy of trastuzumab treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We can't figure out the monetization strategy.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {๐Ÿ”}

tincr, cells, cancer, expression, trastuzumab, breast, pubmed, article, fig, cell, resistance, google, scholar, patients, mirb, trastuzumabresistant, cas, snail, emt, compared, assay, analysis, central, treatment, group, performed, rna, lncrna, parental, chen, qpcr, lncrnas, showed, antibody, data, lines, protein, therapy, hospital, acetylation, human, tissues, enrichment, shnc, cat, level, significantly, mice, study, upregulated,

Topics {โœ’๏ธ}

tumor suppressors mir-125a-5p regulating mir-544a/fbxw7 axis tincr/stau1/cdkn2b signaling axis mir-181a-5p-mediated regulation disrupting sirt6-mediated de-acetylation generate dnaโ€“protein cross-links article download pdf accompanied epithelial-mesenchymal transition sds-page gel electrophoresis inhibiting cul4a-mediated ubiquitination impeding mir-18a repression van der stelt-frissen pi3k/akt signaling pathway ez-magna chip kit wnt/beta-catenin signaling 100โ€‰ng/ml cholera toxin anti-mir-125b rescued mir-125b significantly rescued braf-activated mapk pathway anti-mir-125b abrogated 3โ€‰ml rnase-free h2o nucleo-cytoplasmic separation experiment trastuzumab-resistant cell lines mir-125b-dependent manner mir-125b targets erythropoietin matrigel-based transwell assay mir-125b significantly suppressed epithelial-mesenchymal transition progression-free survival time 4โ€‰ฮผm-thick tma slides progression-free survival showed anti-mir-125b reversed zinc-finger transcription factors hormone receptor-positive full access trastuzumab resistance-related metastasis kaplan-meier analysis showed tincr sponged mir-125b bt474-tr cell lines h3k27 acetylation-induced upregulation trastuzumab-res`istant cells sh-tincr-induced suppression agap2-as1 trastuzumab resistance-induced emt resistance-induced emt process tincr knockdown-induced inhibition anti-n-cadherin antibody mir-125b axis resistance-accompanied emt process negative control sh-nc

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:RETRACTED ARTICLE: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
         description:Trastuzumab resistance followed by metastasis is a major obstacle for improving the clinical outcome of patients with advanced human epidermal growth factor receptor 2-positive (HER-2+) breast cancer. While long non-coding RNAs (lncRNAs) can modulate cell behavior, the contribution of these RNAs in trastuzumab resistance and metastasis of HER-2+ breast cancer is not well known. In this study, we sought to identify the regulatory role of lncRNA in trastuzumab resistance and accompanied Epithelial-mesenchymal Transition (EMT) process in advanced HER-2+ breast cancer. Trastuzumab-resistant SKBR-3-TR and BT474-TR cell lines were established by grafting SKBR-3 and BT474 cells into mouse models and subjected to trastuzumab treatment. LncRNA microarray followed by quantitative reverse transcription PCR (qRT-PCR) was carried out to verify the differentially expressed lncRNAs. Western blotting, bioinformatics analysis, immunofluorescence assay and immunoprecipitation assays (ChIP and RIP) were performed to identify the involvement and functional interactions between H3K27 acetylation and terminal differentiation-induced non-coding RNA (TINCR) or between TINCR and its downstream genes including miR-125b, HER-2 and Snail-1. In addition, a series of in vitro and in vivo assays were performed to assess the functions of TINCR. An increase in both, IC50 value of trastuzumab and EMT was observed in the established trastuzumab-resistant cell lines. The expression level of TINCR was significantly increased in trastuzumab-resistant cells when compared with sensitive cells. Knockdown of TINCR reversed the trastuzumab resistance and the acquired EMT in these cells. TINCR was detected in the cytoplasm of breast cancer cells and could sponge miR-125b, thereby releasing HER-2 and inducing trastuzumab resistance. In addition, Snail-1 was found to be the target gene of miR-125b and overexpression of Snail-1 could reverse the suppressed migration, invasion, and EMT caused by TINCR silencing. The upregulation of TINCR in breast cancer was attributed to the CREB-binding protein (CBP)-mediated H3K27 acetylation at the promoter region of TINCR. Clinically, HER-2+ breast cancer patients with high TINCR expression levels were associated with poor response to trastuzumab therapy and shorter survival time. TINCR could promote trastuzumab resistance and the accompanied EMT process in breast cancer. Therefore, TINCR might be a potential indicator for prognosis and a therapeutic target to enhance the clinical efficacy of trastuzumab treatment.
         datePublished:2019-01-08T00:00:00Z
         dateModified:2022-06-29T00:00:00Z
         pageStart:1
         pageEnd:18
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-018-0931-9
         keywords:
            Breast cancer
            Trastuzumab
            TINCR
            miR-125b
            HER-2
            Snail-1
            H3K27 acetylation
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig9_HTML.png
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Huaying Dong
               url:http://orcid.org/0000-0002-4905-6940
               affiliation:
                     name:Hainan Medical University
                     address:
                        name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jianguo Hu
               affiliation:
                     name:Chongqing Medical University
                     address:
                        name:Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kejian Zou
               affiliation:
                     name:Hainan Medical University
                     address:
                        name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mulin Ye
               affiliation:
                     name:Hainan Medical University
                     address:
                        name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuanwen Chen
               affiliation:
                     name:University of Chinese Academy of Science
                     address:
                        name:Department of General Surgery, Chongqing Renji Hospital, University of Chinese Academy of Science, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chengyi Wu
               affiliation:
                     name:Chongqing Medical University
                     address:
                        name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Chen
               affiliation:
                     name:Chongqing Medical University
                     address:
                        name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Mingli Han
               affiliation:
                     name:The First Affiliated Hospital of Zhengzhou University
                     address:
                        name:Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:RETRACTED ARTICLE: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
      description:Trastuzumab resistance followed by metastasis is a major obstacle for improving the clinical outcome of patients with advanced human epidermal growth factor receptor 2-positive (HER-2+) breast cancer. While long non-coding RNAs (lncRNAs) can modulate cell behavior, the contribution of these RNAs in trastuzumab resistance and metastasis of HER-2+ breast cancer is not well known. In this study, we sought to identify the regulatory role of lncRNA in trastuzumab resistance and accompanied Epithelial-mesenchymal Transition (EMT) process in advanced HER-2+ breast cancer. Trastuzumab-resistant SKBR-3-TR and BT474-TR cell lines were established by grafting SKBR-3 and BT474 cells into mouse models and subjected to trastuzumab treatment. LncRNA microarray followed by quantitative reverse transcription PCR (qRT-PCR) was carried out to verify the differentially expressed lncRNAs. Western blotting, bioinformatics analysis, immunofluorescence assay and immunoprecipitation assays (ChIP and RIP) were performed to identify the involvement and functional interactions between H3K27 acetylation and terminal differentiation-induced non-coding RNA (TINCR) or between TINCR and its downstream genes including miR-125b, HER-2 and Snail-1. In addition, a series of in vitro and in vivo assays were performed to assess the functions of TINCR. An increase in both, IC50 value of trastuzumab and EMT was observed in the established trastuzumab-resistant cell lines. The expression level of TINCR was significantly increased in trastuzumab-resistant cells when compared with sensitive cells. Knockdown of TINCR reversed the trastuzumab resistance and the acquired EMT in these cells. TINCR was detected in the cytoplasm of breast cancer cells and could sponge miR-125b, thereby releasing HER-2 and inducing trastuzumab resistance. In addition, Snail-1 was found to be the target gene of miR-125b and overexpression of Snail-1 could reverse the suppressed migration, invasion, and EMT caused by TINCR silencing. The upregulation of TINCR in breast cancer was attributed to the CREB-binding protein (CBP)-mediated H3K27 acetylation at the promoter region of TINCR. Clinically, HER-2+ breast cancer patients with high TINCR expression levels were associated with poor response to trastuzumab therapy and shorter survival time. TINCR could promote trastuzumab resistance and the accompanied EMT process in breast cancer. Therefore, TINCR might be a potential indicator for prognosis and a therapeutic target to enhance the clinical efficacy of trastuzumab treatment.
      datePublished:2019-01-08T00:00:00Z
      dateModified:2022-06-29T00:00:00Z
      pageStart:1
      pageEnd:18
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-018-0931-9
      keywords:
         Breast cancer
         Trastuzumab
         TINCR
         miR-125b
         HER-2
         Snail-1
         H3K27 acetylation
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-018-0931-9/MediaObjects/12943_2018_931_Fig9_HTML.png
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Huaying Dong
            url:http://orcid.org/0000-0002-4905-6940
            affiliation:
                  name:Hainan Medical University
                  address:
                     name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jianguo Hu
            affiliation:
                  name:Chongqing Medical University
                  address:
                     name:Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kejian Zou
            affiliation:
                  name:Hainan Medical University
                  address:
                     name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mulin Ye
            affiliation:
                  name:Hainan Medical University
                  address:
                     name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuanwen Chen
            affiliation:
                  name:University of Chinese Academy of Science
                  address:
                     name:Department of General Surgery, Chongqing Renji Hospital, University of Chinese Academy of Science, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chengyi Wu
            affiliation:
                  name:Chongqing Medical University
                  address:
                     name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Chen
            affiliation:
                  name:Chongqing Medical University
                  address:
                     name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Mingli Han
            affiliation:
                  name:The First Affiliated Hospital of Zhengzhou University
                  address:
                     name:Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:18
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hainan Medical University
      address:
         name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
         type:PostalAddress
      name:Chongqing Medical University
      address:
         name:Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Hainan Medical University
      address:
         name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
         type:PostalAddress
      name:Hainan Medical University
      address:
         name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
         type:PostalAddress
      name:University of Chinese Academy of Science
      address:
         name:Department of General Surgery, Chongqing Renji Hospital, University of Chinese Academy of Science, Chongqing, China
         type:PostalAddress
      name:Chongqing Medical University
      address:
         name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:Chongqing Medical University
      address:
         name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Zhengzhou University
      address:
         name:Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Huaying Dong
      url:http://orcid.org/0000-0002-4905-6940
      affiliation:
            name:Hainan Medical University
            address:
               name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jianguo Hu
      affiliation:
            name:Chongqing Medical University
            address:
               name:Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Kejian Zou
      affiliation:
            name:Hainan Medical University
            address:
               name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
               type:PostalAddress
            type:Organization
      name:Mulin Ye
      affiliation:
            name:Hainan Medical University
            address:
               name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
               type:PostalAddress
            type:Organization
      name:Yuanwen Chen
      affiliation:
            name:University of Chinese Academy of Science
            address:
               name:Department of General Surgery, Chongqing Renji Hospital, University of Chinese Academy of Science, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Chengyi Wu
      affiliation:
            name:Chongqing Medical University
            address:
               name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Xin Chen
      affiliation:
            name:Chongqing Medical University
            address:
               name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Mingli Han
      affiliation:
            name:The First Affiliated Hospital of Zhengzhou University
            address:
               name:Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
      name:Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
      name:Department of General Surgery, Hainan General Hospital, Hainan Medical University, Haikou City, China
      name:Department of General Surgery, Chongqing Renji Hospital, University of Chinese Academy of Science, Chongqing, China
      name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of General Surgery, The Frist Affiliated Hospital, Chongqing Medical University, Chongqing, China
      name:Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

External Links {๐Ÿ”—}(211)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

5.11s.